Andrew Muir

Andrew is a Director at the venture capital firm, Midven. As Fund Principal of the UK Innovation & Science Seed Fund and the Early Advantage Fund, Andrew led two rounds of investment into Atelerix

Read more about Andrew Muir

Management Team

Dr Edwin Wagena

Chief Executive Officer

Ed is an experienced hands-on senior executive, trained as epidemiologist with a PhD in Medicine, with more than 20 years of experience in drug development.

Read more about Dr Edwin Wagena

Dr Steve Swioklo

Chief Scientific Officer

Steve is a co-founder of Atelerix and Chief Scientific Officer for the company, with a deep interest in the development of new technologies for biomedical applications.

Read more about Dr Steve Swioklo

An innovative solution for storing and transporting cells and tissues at room temperature.